Benjamin Moutier
Senior Vice President, Vaccines & Immune Therapies
AstraZeneca
Mr. Moutier is Senior Vice-President, Vaccines & Immune Therapies, AstraZeneca. In this capacity, he is responsible for R&D, Commercial, Medical Affairs and cross-functional activities for the unit. AstraZeneca’s Vaccines & Immune Therapies Unit is building an innovative portfolio of transformative products including antibodies and vaccines to tackle some of the leading global public health threats across viral respiratory diseases, serious bacterial infections, and chronic viral infections.
Benjamin joined AstraZeneca in 2011 and has held different leadership positions at global and local level. He was Vice-President, Global Franchise Head, Haematology where he was instrumental in expanding the franchise pipeline, driving commercial performance and advancing the broader haematology strategy. He was a member of the Cell Therapy Enterprise Leadership Team, and a key contributor to AstraZeneca’s cell therapy efforts, actively shaping future capabilities in this space. He has also served in other leadership positions across the Respiratory and Oncology businesses, including Head of Oncology, France, and Global Commercial Head, Immuno-Oncology.
Throughout his time at the company, Benjamin has delivered rapid growth, achieved numerous successful launches, and delivered on multiple Phase III clinical trials.
Benjamin started his career at the Boston Consulting Group, as a Consultant in Strategy, Operations and Corporate Development, working with large pharmaceutical companies and healthcare authorities across US and Europe.
Benjamin graduated from Ecole Centrale Paris with a Master’s in Applied Mathematics and from Sciences-Po Paris with a Master’s in Economics.
